Sponsor or institution
Clinical trials and research at Shenzhen Salubris Pharmaceuticals Co., Ltd.
As of November 12, 2026, Find a Trial lists 6 clinical trials run by Shenzhen Salubris Pharmaceuticals Co., Ltd. that are recruiting, in China. 1 was first registered in the last 30 days. By phase: Phase 2 (3), Phase 4 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 1New in 30 days
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Long-term GW906 treatment for people with essential hypertension | — | Shanghai, Shanghai Municipality | Recruiting | Oct 19, 2026 |
| SAL0140 at different doses for uncontrolled hypertension | Phase 2 | Beijing, Beijing Municipality | Recruiting | Jun 17, 2026 |
| Different doses and schedules of SAL056 for postmenopausal osteoporosis | Phase 2 | Beijing, Beijing Municipality | Recruiting | May 12, 2026 |
| Allisartan Isoproxil single-dose pharmacokinetics in healthy Chinese adults | Phase 4 | Shenzhen, Guangdong | Recruiting | Sep 16, 2025 |
| SAL0140 safety and dosing in healthy Chinese adults | Phase 1 | Guangzhou, Guangdong | Recruiting | Jul 4, 2025 |
| Treatment of chemotherapy-induced anemia with SAL-0951 | Phase 2 | Shanghai, Shanghai Municipality | Recruiting | Dec 17, 2024 |
All recruiting trials (6)
-
Long-term GW906 treatment for people with essential hypertension
This trial tests whether long-term GW906 injections are safe and effective for adults with essential hypertension who completed an earlier GW906 study.
-
SAL0140 at different doses for uncontrolled hypertension
This trial tests whether SAL0140 at various doses can help people with uncontrolled high blood pressure compared to placebo.
-
Different doses and schedules of SAL056 for postmenopausal osteoporosis
This trial will test whether different doses and dosing schedules of SAL056 are safe for postmenopausal women with osteoporosis.
-
Allisartan Isoproxil single-dose pharmacokinetics in healthy Chinese adults
We will test single doses of Allisartan Isoproxil (240, 480, 720 mg) versus placebo in healthy Chinese adults to see how the drug is absorbed and tolerated.
-
SAL0140 safety and dosing in healthy Chinese adults
This project will test whether SAL0140 is safe, well tolerated, and how it is processed by the body in healthy Chinese adults to guide dosing for uncontrolled hypertension.
-
Treatment of chemotherapy-induced anemia with SAL-0951
This study is testing a new treatment called SAL-0951 to see if it can help people with cancer who are experiencing anemia from chemotherapy feel better.
Quick answers
How many clinical trials run by Shenzhen Salubris Pharmaceuticals Co., Ltd. are recruiting right now?
6, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 4: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.